Skip to main content

Table 2 Comparison of baseline variables in patients receiving TDF and ETV

From: Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection

Variable TDF ETV P
Patients, n (%) 107 (45.92) 126 (54.08)  
Male sex, n (%) 82 (76.63) 107 (84.92) 0.08
Age, M (range) 52 (25–69) 55 (26–73) 0.31
CTP class A/B/C, n (%)      0.11
 A 105 (98.13) 122 (96.82)  
 B 2 (1.87) 4 (3.18)  
 C 0   0   
HBV DNA, log copies/ml 3.7 (3.0–4.7) 4.1 (3.0–5.1) 0.07
HBeAg postive, n (%) 76 (71.03) 88 (69.84) 0.14
Cirrhosis, n (%) 59 (55.14) 37 (29.36) 0.03
AFP, ng/mL, M (range) 97.5 (7.8–1210) 109 (10.3–1210) 0.33
Tumor maximum size, cm, M (range) 3.8 (2.8–9.7) 4.4 (2.6–8.5)  
TBIL, mmol/L, M (range) 4.78 (2.6–64.7) 7.41 (3.90–54.30) 0.16
ALT, IU/L, M (range) 21 (11–41) 27 (19–57) 0.11
AST, IU/L, M (range) 28 (19–56) 21 (20–78) 0.41
ALP, IU/L, M (range) 49 (45–111) 58 (51–187) 0.09
ALB, g/L, M (range) 3.5 (2.3–5.7) 4.1 (2.5–5.1) 0.64
PLT, 10^9/L, M (range) 134.24 (79–241) 183 (99–210) 0.21
PT, s, M (range) 11.9 (11.3–12.6) 12.5 (11.7–13.6) 0.08
INR, M (range) 1.01 (0.77–1.24) 0.97 (0.81–1.21) 0.51
  1. AFP = α-fetoprotein, ALB = albumin, ALP = alkaline phosphatase,ALT = alanine aminotransferase, AST = aspartate aminotransferase, CTP=Child–Trucott–Pugh score, HBV = hepatitis B virus, INR = international normalized ratio, PLT = platelet, PT = prothrombin time, TBIL = total bilirubin